What is NextCure Inc?
, a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 29.31M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.